Kusuri no Aoki First-Quarter Net Profit Jumps 36.4% to ¥6,866 Million as Fresh-Food Sales Surge 43% and Its Shikoku Stores More Than Double Revenue

Net sales rose 13.8% to ¥159,042 million in the three months to August 20, operating profit 16.0% to ¥8,424 million and profit attributable to owners of the parent 36.4% to ¥6,866 million. Fresh-food sales jumped 42.8%. The drugstore chain said results were broadly on plan and kept its full-year forecast of ¥32,000 million of operating profit and a ¥64.00 dividend.

Kusuri no Aoki Q1 FY5/2027 earnings summary

Food and fresh produce power the quarter

Kusuri no Aoki Holdings Co., Ltd. (TSE: 3549), the Ishikawa-based drugstore chain, published consolidated results for the first quarter of FY5/2027, the period from May 21 to August 20, 2026, on October 1, 2026 under Japanese GAAP. Net sales rose 13.8% to ¥159,042 million, operating profit 16.0% to ¥8,424 million, ordinary profit 17.6% to ¥8,568 million and profit attributable to owners of the parent 36.4% to ¥6,866 million. Earnings per share rose 43.9% to ¥72.30, because the average share count fell to 94,963,067 from 100,173,422 a year earlier. The quarterly statements were reviewed by the company's auditor on a voluntary basis.

The company is pushing a "Food & Drug" format, opening larger stores that carry a full grocery range and building its know-how in fresh produce, so customers can do all their shopping in one place. That showed in the mix: food sales rose 15.3% to ¥65,812 million and fresh food, covering fruit and vegetables, meat, fish and prepared dishes, 42.8% to ¥22,574 million, lifting its share of sales from 11.3% to 14.2%. Dispensing-pharmacy sales grew 13.9% to ¥15,931 million. Traditional drugstore lines grew far more slowly: household and life products 4.6%, beauty 4.5%, while health products, which include medicines, slipped 0.2%.

Shikoku sales more than double

The chain opened 21 drugstores, nine in Hokushinetsu, six in Shikoku, five in Tokai and one in Kanto, plus 20 in-store dispensing pharmacies, and closed five drugstores and two pharmacies. It ended the quarter with 1,154 outlets: 1,123 drugstores, 710 of them with a pharmacy, six stand-alone pharmacies and 25 supermarkets. By region, sales in its home Hokushinetsu area rose 17.1% to ¥67,372 million, while Shikoku, where it now has 35 stores, jumped 152.9% to ¥7,571 million. Growth was slowest in Kanto, at 3.0%, and Tokai, at 4.4%.

Margins edge up; tax charge falls

Gross profit rose 14.1% to ¥42,132 million, slightly faster than sales, and selling, general and administrative expenses rose 13.6% to ¥33,707 million, so operating profit grew faster than revenue. Depreciation rose to ¥3,890 million from ¥3,327 million and goodwill amortisation to ¥414 million from ¥283 million. Pre-tax profit rose 18.6% to ¥8,570 million, but income taxes fell to ¥1,703 million from ¥2,196 million, which is why net profit grew twice as fast as pre-tax profit; the filing does not explain the lower tax charge. Comprehensive income rose 51.0% to ¥8,559 million on a ¥1,693 million gain on securities held.

Balance sheet and outlook

Total assets fell ¥4,487 million to ¥406,449 million from May 20, 2026, as other receivables fell ¥6,386 million and trade receivables ¥3,360 million, while buildings and investment securities rose. Liabilities fell ¥8,489 million, including ¥6,136 million less long-term borrowing and ¥2,243 million less income tax payable, and the equity ratio rose to 35.7% from 34.3%. Kusuri no Aoki kept the forecasts it published on July 2, 2026: for the first half, operating profit of ¥15,500 million (+14.9%) on sales of ¥318,000 million; for the full year, sales of ¥640,000 million (+12.9%), operating profit of ¥32,000 million (+18.1%), ordinary profit of ¥30,800 million (+11.1%) and net profit of ¥19,000 million (+10.9%), or ¥200.08 per share. The planned dividend is ¥32.00 at the interim and ¥32.00 at year end, ¥64.00 in total, against ¥56.00 for FY5/2026, of which ¥40.00 was a 40th-anniversary commemorative payment.

Kusuri no Aoki Holdings Co., Ltd. — Q1 FY5/2027 (May 21 – August 20, 2026), Japanese GAAP, consolidated. Balance-sheet rows compare August 20, 2026 with May 20, 2026; guidance and dividend rows are full-year FY5/2027 against FY5/2026. "—" indicates a figure not disclosed.
MetricQ1 FY5/2027Q1 FY5/2026Change
Net sales (¥ million)159,042139,735+13.8%
Gross profit (¥ million)42,13236,936+14.1%
Gross margin26.5%26.4%+0.1 pt
SG&A expenses (¥ million)33,70729,672+13.6%
Operating profit (¥ million)8,4247,263+16.0%
Ordinary profit (¥ million)8,5687,284+17.6%
Pre-tax profit (¥ million)8,5707,229+18.6%
Net profit attrib. to owners of parent (¥ million)6,8665,033+36.4%
EPS (¥)72.3050.25+43.9%
Comprehensive income (¥ million)8,5595,669+51.0%
Food sales (¥ million)65,81257,098+15.3%
Fresh food sales (¥ million)22,57415,803+42.8%
Dispensing pharmacy sales (¥ million)15,93113,989+13.9%
Health sales (¥ million)11,23511,256−0.2%
Beauty sales (¥ million)17,57016,820+4.5%
Household & life sales (¥ million)25,91724,767+4.6%
Total assets (¥ million)406,449410,937−1.1%
Net assets (¥ million)145,040141,038+2.8%
Equity ratio35.7%34.3%+1.4 pt
FY5/2027 guidance — revenue (¥ million)640,000—+12.9%
FY5/2027 guidance — operating profit (¥ million)32,000—+18.1%
FY5/2027 guidance — ordinary profit (¥ million)30,800—+11.1%
FY5/2027 guidance — net profit (¥ million)19,000—+10.9%
FY5/2027 guidance — EPS (¥)200.08—n.m.
Annual dividend per share (¥)64.0056.00+14.3%

JapanStockPulse provides informational content only and does not constitute investment advice. Figures are taken from the company's published earnings short report and may be subject to subsequent revision.